• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMERIEUX, SA VITEK® MS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMERIEUX, SA VITEK® MS Back to Search Results
Model Number 410895
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Type  malfunction  
Event Description
A customer from the united kingdom reported to biomérieux a misidentification in association with the vitek® ms instrument.The customer reported that the vitek® ms result was streptococcus dysgalactiae, and the alternative method (pro-lab streptococcal grouping kit) result was group a streptococcus.The expected identification was unknown.The customer stated an incorrect result of streptococcus dysgalactiae was reported to the physician and the patient treatment was not impacted.There was a delay in reporting results.There is no indication or report from the hospital or treating physician to biomérieux that the discrepant result led to any adverse event related to the patient's state of health.A biomérieux internal investigation will be initiated.
 
Manufacturer Narrative
A customer from the (b)(6) reported a misidentification with a vitek® ms result of streptococcus dysgalactiae, and the alternative method result was group a streptococcus.The expected identification was unknown.An investigation was performed.Analysis of the instrument files confirmed the vitek ms system was operational during the customer test.Regarding the customer data, the most probable identification is streptococcus dysgalactie subspecies equisimilis.This identification was confirmed by a reference laboratory as streptococcus dysgalactie subspecies equisimilis - atypically lancefield group a.The data files provided by the customer were reprocessed with vitek ms kb v3.0 (clinical) and vitek ms kb v3.1 (for industry) and all spots gave low discrimination between str.Dys.Dysgalactiae and str.Dys.Equisimilis.The vitek ms worked as intended.There are the following limitations in the knowledge base user manual ref.161150-556-b for vitek ms clinical use v3.0: for str.Dys.Dysgalactiae and str.Dys.Equisimilis: subspecies or species group is displayed as a low discrimination result.A choice should be made between the proposed subspecies or species.Additional laboratory tests as determined by microbiology laboratory protocols for low discrimination results are necessary for the completion of the organism identification.The investigation concluded there was no issue with vitek ms.The identification of the strain was confirmed by reference laboratory as streptococcus dysgalactie subspecies equisimilis (atypically lancefield group a).The vitek ms worked as intended.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VITEK® MS
Type of Device
VITEK® MS
Manufacturer (Section D)
BIOMERIEUX, SA
3 route de port michaud
la balme les grottes isere, 38390
FR  38390
MDR Report Key7045833
MDR Text Key93458362
Report Number3002769706-2017-00376
Device Sequence Number1
Product Code PEX
Combination Product (y/n)N
PMA/PMN Number
DEN130013
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 01/10/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/20/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number410895
Other Device ID Number03573026359119
Was Device Available for Evaluation? No
Date Manufacturer Received12/14/2017
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-